This increased cytokine production by Arl4d−/− CD4 T cells, however, does not exacerbate CD4 T-cell-driven colitis but rather protects from extensive tissue inflammation and cell infiltration (Figure 2). The gene discussed is ARL4D; the disease is colitis.